Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulvar and vaginal disorders.

K D Hatch1

  • 1Department of Obstetrics and Gynecology, University of Arizona Health Sciences Center, Tucson 85724.

Current Opinion in Obstetrics & Gynecology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrosurgical Excision Procedures: LLETZ and LEEP-A Critical Analysis.

Journal of lower genital tract disease·2015
Same author

Response 2.

Journal of lower genital tract disease·2015
Same author

Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.

The Journal of reproductive medicine·2001
Same author

Wilms' tumor of the cervix: a case report and review of the literature.

Gynecologic oncology·2000
Same author

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.

Gynecologic oncology·1998
Same author

The role of operative laparoscopy to evaluate candidates for pelvic exenteration.

Gynecologic oncology·1998
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Vulvovaginitis, often caused by bacterial vaginosis, Candida, or Trichomonas, is a common gynecological issue. Human papillomavirus (HPV) is a growing concern, with frequent exposure noted from birth and during sexual activity, and interferon shows promise for HPV treatment.

Area of Science:

  • Gynecology
  • Infectious Diseases
  • Virology

Background:

  • Vulvovaginitis represents a frequent reason for gynecological consultations.
  • Common etiologies include bacterial vaginosis, Candida species, and Trichomonas vaginalis.
  • Human papillomavirus (HPV) presents significant diagnostic and therapeutic challenges.

Purpose of the Study:

  • To summarize the common causes of vulvovaginitis.
  • To highlight the increasing prevalence and impact of HPV.
  • To review potential therapeutic strategies for HPV.

Main Methods:

  • Literature review of common vulvovaginitis causes.
  • Analysis of HPV DNA testing data regarding exposure patterns.
  • Summary of existing research on interferon efficacy for HPV.

Related Experiment Videos

Main Results:

  • Bacterial vaginosis, Candida, and Trichomonas are the primary causes of vulvovaginitis.
  • HPV DNA testing indicates frequent perinatal and sexual transmission.
  • Interferon has demonstrated effectiveness in treating certain HPV infections.

Conclusions:

  • Understanding the epidemiology of vulvovaginitis is crucial for effective patient management.
  • HPV infection is widespread, with significant exposure occurring early in life and post-puberty.
  • Interferon offers a potential therapeutic avenue for managing specific HPV-related conditions.